[Implication of the routine administration of phytonadione in hemorrhagic disease of the newborn].
D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D007231:Infant, Newborn; D008297:Male; D011247:Pregnancy; D010837:Vitamin K 1 / Q000627:therapeutic use*; D006475:Vitamin K Deficiency Bleeding / Q000517:prevention & control*
D010837:Vitamin K 1